🔥 We have been featured on Shark Tank India.Episode 13

🔥 We have been featured on Shark Tank India

logologo
Search anything
Ctrl+K
gift
arrow
WhatsApp Icon

Stock Summary and Key Metrics













Investment Checklist




























Forecasts

No ConstituentsNo Constituents

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Ask AI

mockupmockup

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

View Standalone

Total Figures
QoQ Changes
Total Figures
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales24232122202021232422
Expenses22231919181818192018
Operating Profit1.22-0.632.672.212.322.703.033.283.923.63
OPM %5.15-2.7812.5310.2811.4513.2014.2914.4916.6716.62
Other Income0.223.130.680.140.180.530.490.860.420.50
Interest1.311.441.761.511.501.891.561.441.401.66
Depreciation1.591.451.431.481.511.691.681.661.641.62
Profit Before Tax-1.46-0.390.17-0.65-0.51-0.340.281.031.300.84
Tax %24.6648.725.88-6.15-7.84-58.82-28.5711.6523.8530.95
Net Profit-1.10-0.200.15-0.69-0.55-0.540.360.911.000.59
EPS in Rs-1.07-0.200.15-0.67-0.53-0.530.350.890.970.57

Consolidated Profit Loss (in ₹ Crores)

View Standalone

View Standalone

Total Figures
YoY Changes
Total Figures
Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales10891817091119110908385
Expenses937770758510294867373
Operating Profit151411-4.605.2917164.091011
OPM %13.8615.2214.01-6.565.8414.5914.634.5312.3013.40
Other Income1.372.230.18155.581.684.505.221.342.06
Interest4.185.036.586.955.313.494.175.786.466.39
Depreciation4.334.785.746.136.116.317.016.096.356.54
Profit Before Tax7.896.31-0.81-3.00-0.559.269.48-2.56-1.220.46
Tax %36.2328.7922.8921.14-15.3130.7029.5430.00-16.5360.87
Net Profit5.034.49-0.62-2.37-0.646.426.68-1.79-1.420.18
EPS in Rs-0.67-4.85-0.616.266.51-1.75-1.382.78
Dividend Payout %0.000.000.000.000.000.000.000.000.00

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

View Standalone

Total Figures
YoY Changes
Total Figures
Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital101010101010101010
Reserves333737343340465857
Borrowings405749445035376669
Other Liabilities363842412725282426
Total Liabilities119142138130121110121158162
Fixed Assets607169707070708794
CWIP0.120.192.470.010.011.750.015.660.09
Investments0.000.100.110.111.071.030.000.000.00
Other Assets597166605037506668
Total Assets119142138130121110121158162

Consolidated Cash Flows (in ₹ Crores)

View Standalone

View Standalone

Total Figures
YoY Changes
Total Figures
Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity115.48154.3117237.47-1512
Cash from Investing Activity-13-17-2.80-2.52-11-4.24-3.40-10-7.70
Cash from Financing Activity2.2311-12-1.56-6.42-19-3.7525-3.87
Net Cash Flow0.17-0.670.300.23-0.79-0.290.32-0.51-0.05

Shareholdings

Shareholding History

Quarterly
Yearly
Quarterly
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters73.53%73.53%73.53%73.53%73.53%73.53%73.53%73.53%73.53%73.53%73.53%73.53%
FIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DIIs0.10%0.10%0.10%0.10%0.10%0.10%0.10%0.10%0.10%0.10%0.10%0.10%
Public26.37%26.37%26.37%26.37%26.37%26.37%26.37%26.37%26.37%26.37%26.37%26.37%
Total Shareholders7,1117,0427,0817,0106,8586,5946,5076,5506,5416,4756,4306,399

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

professionalIcon

Upgrade

transaction-premiumtransaction-premium

Projection

No ConstituentsNo Constituents

Documents

Presentations
Concalls
Reports
Presentations
iconiconicon

Investor Presentation

Q2 FY19

iconiconicon

Investor Presentation

Q4 FY18

iconiconicon

Investor Presentation

Q4 FY18

lock

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

iconiconicon

Investor Presentation

Q3 FY18

lock

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

iconiconicon

Investor Presentation

Q3 FY18

lock

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

iconiconicon

Investor Presentation

Q2 FY18

lock

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

iconiconicon

Investor Presentation

Q1 FY18

lock

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

iconiconicon

Investor Presentation

Q4 FY17

lock

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Showing 1 - 8 of 13

Actions

Action Type




























































AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Ask AI

ai-corner-premiumai-corner-premium
ai-corner-premiumai-corner-premium

Frequently Asked Questions about Sunil Healthcare Ltd

Sunil Healthcare Ltd (SUNLOC) is currently trading at 67.95 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Sunil Healthcare Limited is a leading manufacturer of Empty Hard Gelatin Capsule Shells in India, known for high-quality production standards. The company has expanded significantly since its inception, increasing its capsule production capacity to 15 billion shells annually by 2021-22. Sunil Healthcare also ventured into the food business, under the 'Sunloc Foods' brand, focusing on nuts and edible items like cashews and pistachios. The company has established subsidiaries in the USA and Mexico to extend its market reach and capitalize on international demand. Sunil Healthcare's recognition as a 'Star Export House' by the government underscores its substantial export capabilities and market presence.

Over the past 52 weeks, Sunil Healthcare Ltd has traded between a low of ₹60.55 and a high of ₹88.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Sunil Healthcare Ltd has a market capitalization of approximately 64.60. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Sunil Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 24.44 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 64.60 Cr, Sunil Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Sunil Healthcare Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Sunil Healthcare Ltd is 24.44. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.